GRHL1 and neuroblastoma: In brain cancer, particularly primary neuroblastoma, an early childhood neuroendocrine tumour originating from neural crest cells, GRHL1 functions as a tumour suppressor and its upregulation correlates with a favourable patient prognosis [39].